Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Market Cap	7.35B +36.9%
Revenue (ttm)	15.45B +2.1%
Net Income	313.00M -65.1%
EPS	14.50 -65.0%
Shares Out	21.54M
PE Ratio	23.52
Forward PE	n/a
Dividend	10.00 (2.93%)
Ex-Dividend Date	Mar 30, 2026

Volume	42,100
Open	347.00
Previous Close	347.00
Day's Range	340.00 - 347.00
52-Week Range	253.00 - 640.00
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufactur...

• Industry: Chemicals
• Sector: Materials
• Founded: 1947
• Employees: 296
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4531

Financial Performance

In fiscal year 2026, Yuki Gosei Kogyo's revenue was 15.45 billion, an increase of 2.12% compared to the previous year's 15.13 billion. Earnings were 313.00 million, a decrease of -65.07%.